A
Aldeyra Therapeutics (ALDX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aldeyra Therapeutics (ALDX)
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dr... Read more
- USD4.94
- USD5.11
- USD4.94
- USD7.20
- -9.10%
- --
- 745.82k
- 838.26k
- 323M
- 1.14
- -15.20%
Stock News
3 hours ago
China's Huawei Unveils AI Supercluster in Direct Challenge to Nvidia
Yahoo
3 hours ago
Boycott Disney over pulling Jimmy Kimmel? Why the company will likely fare better than Tesla and Bud Light did.
MarketWatch
4 hours ago
How much homeowners pay in property taxes in every U.S. state—in one map
CNBC
4 hours ago
FTC sues Ticketmaster, Live Nation, alleging 'illegal' ticket resale tactics
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
